Using PET to detect fibrosis
January 21st, 2021
Fibrosis is a common pathway in many diseases affecting organs such as the liver, kidney, and heart. The need to develop and apply non-invasive and sensitive biomarkers that can detect changes in fibrosis development as response to interventions is high. Researchers from Uppsala University including Olof Eriksson (PET Imaging Director at Antaros Medical) have authored an article looking at the targeting of collage type I by molecular imaging using positron emission tomography (PET) as a direct and quantitative way to assess fibrosis.
Ex vivo autoradiograms of PET tracer binding to collagen type I in fibrotic NASH vs healthy liver tissue (left) and the staining of collagen in the corresponding tissue (right) in mice
Back to all news